Low-dose ketamine shows promise for pain relief in emergency department patients
New AEM study finds low-dose ketamine an effective adjunct to morphine for managing acute pain
2024-11-19
(Press-News.org) Des Plaines, IL — A new study that investigates low-dose ketamine (LDK) as an adjunct to morphine for treating acute pain has been published in the October issue of Academic Emergency Medicine (AEM), the peer-reviewed journal of the Society for Academic Emergency Medicine (SAEM).
The study, titled Low-dose ketamine as an adjunct to morphine: A randomized controlled trial among patients with and without current opioid use highlights the potential of low-dose ketamine as a valuable tool in pain management, providing a safe and effective option for emergency medicine physicians managing acute pain.
Pain remains one of the most common and challenging complaints among patients presenting to the emergency department (ED). For individuals with opioid tolerance, achieving effective pain relief can be particularly difficult, as they often require higher doses of opioids, which increases risks of hyperalgesia and withdrawal symptoms. In their randomized, placebo-controlled trial, lead author Stine Fjendbo Galili, MD, and colleagues explored the effectiveness of LDK as an adjunct to morphine in a diverse ED population with varying levels of opioid use. The study demonstrated that a single dose of 0.1 mg/kg of ketamine provided significant reductions in pain scores for 30 minutes compared to a placebo.
The study concluded that LDK may be an effective short-term adjunct analgesic to morphine for managing acute pain, offering relief to both opioid-tolerant and opioid-naïve patients. Importantly, the findings open the door for future research to refine low-dose ketamine administration methods, such as bolus or continuous infusions, to achieve longer-lasting pain relief.
###
ABOUT ACADEMIC EMERGENCY MEDICINE
Academic Emergency Medicine, the monthly journal of Society for Academic Emergency Medicine, features the best in peer-reviewed, cutting-edge original research relevant to the practice and investigation of emergency care. The above study is published open access and can be downloaded by following https://doi.org/10.1111/acem.14983. Journalists wishing to interview the authors may contact Laura Giblin at lgiblin@saem.org.
ABOUT THE SOCIETY FOR ACADEMIC EMERGENCY MEDICINE
SAEM is a 501(c)(3) not-for-profit organization dedicated to the improvement of care of the acutely ill and injured patient by leading the advancement of academic emergency medicine through education and research, advocacy, and professional development. To learn more, visit saem.org.
END
ELSE PRESS RELEASES FROM THIS DATE:
2024-11-19
Research Highlights:
A clinical trial with adults who have atrial fibrillation (AFib) and an implanted heart device found similar improvements to the amount of time they experienced arrhythmia regardless of whether they received standard care (education pamphlets about healthy diet and exercise), followed a lifestyle/risk factor modification program, or took metformin and followed a lifestyle/risk factor modification program.
AFib burden, a measure of how much time a patient experiences atrial arrhythmia, improved during the treatment period — particularly in the standard of care and lifestyle risk factor modification groups.
Lifestyle and risk factor modification was associated ...
2024-11-19
Cognitive neuroscientists in Trinity College Dublin have published new research describing a brand new approach to making habit change achievable and lasting.
This innovative framework has the potential to significantly improve approaches to personal development, as well as the clinical treatment of compulsive disorders (for example obsessive compulsive disorder, addiction, and eating disorders).
The research was led by Dr Eike Buabang, Postdoctoral Research Fellow in the lab of Professor Claire Gillan in the School of Psychology and has been published as a paper, Leveraging ...
2024-11-19
Research Highlights:
The oral medication muvalaplin may safely lower high levels of lipoprotein(a), also known as Lp(a), an independent, inherited risk factor for cardiovascular disease.
Muvalaplin is a small molecule inhibitor that prevents the bonding of the two protein components that combine to make Lp(a). There are no currently FDA-approved medications to lower Lp(a) levels, though other medications are currently being evaluated in clinical trials. Muvalaplin is the first oral medication developed to lower Lp(a) levels.
Results ...
2024-11-19
WEST LAFAYETTE, Ind. — Eradivir, a preclinical biotech company, has developed a patent-pending antiviral therapeutic that reduces lung viral loads of advanced-stage influenza in preclinical studies quicker and more effectively than currently available therapies.
A single intranasal dose of EV25, a bispecific small molecule developed by Eradivir, acts faster than the current standard of care, eliminating the detectable virus within 24 hours. EV25 also has a window of efficacy of 96 hours postinfection, which is broader than the current standard of care.
A ...
2024-11-19
Every fall, millions of Medicare beneficiaries have the chance to pick a new stand-alone prescription drug plan that may be better suited for them, but most stick with the same plan.
A new study published today in Health Affairs Scholar suggests that 52% of Medicare beneficiaries with stand-alone Part D plans did not switch because they made no plan comparisons at all for 2024. Many of these beneficiaries (41%) also reported not knowing how to switch plans.
“Comparing these Medicare Part D plans is hard, so many beneficiaries just don’t do it. But beneficiaries who don’t compare plans may not notice if they are sticking with more expensive plans or ...
2024-11-19
DALLAS, Nov. 19, 2024 —“What Would They Say?” – the powerful spoken word poem produced on video by the American Heart Association, which is celebrating 100 years of lifesaving service as the world’s leading voluntary organization focused on heart and brain health, has taken second place in the 4th Annual Anthem Awards winning the Silver Award in the Education, Art & Culture Campaign - Non-Profit Community Engagement category. This international recognition celebrates the Association’s impactful work and historic commitment ...
2024-11-19
Even when their parents are lawyers, doctors, or executives, Black Britons are substantially more likely to end up in working class jobs than their White peers, a new study from the University of Kent reveals.
Funded by the Leverhulme Trust, this research shows that Black men from the most advantaged families are three times more likely than White men from similar backgrounds to be in working class jobs beyond age 30. Black women are also twice as likely as White women to experience this kind of downward mobility. This is true even after removing ...
2024-11-19
Fukuoka, Japan—We all age. And while humanity’s life expectancy has increased dramatically in the modern era, we still struggle with the inevitable health issues our bodies face as we get up in the years. For example, the decrease of muscle mass and function, leading to weakness and atrophy. This is a pressing concern in a super-aging society like Japan where—while people live longer—without proper muscle strength, quality of life can be drastically diminished.
In findings that may eventually lead to targeted ...
2024-11-19
“Brain aging is a biological process that comprehends degenerative, adaptive, and regenerative brain changes that elapse through maturity until the elderly.”
BUFFALO, NY- November 19, 2024 – A new review was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science), on October 29, 2024, Volume 16, Issue 20, titled, ”Brain aging and Alzheimer’s disease, a perspective from non-human primates.“
In the review, Ferrer Isidro from the University of Barcelona and Reial Acadèmia de Medicina de Catalunya, explores the differences in ...
2024-11-19
Individual cells appear capable of learning, a behaviour once deemed exclusive to animals with brains and complex nervous systems, according to the findings of a new study led by researchers at the Centre for Genomic Regulation (CRG) in Barcelona and Harvard Medical School in Boston.
The findings, published today in the journal Current Biology, could represent an important shift in how we view the fundamental units of life.
“Rather than following pre-programmed genetic instructions, cells are elevated to entities equipped ...
LAST 30 PRESS RELEASES:
[Press-News.org] Low-dose ketamine shows promise for pain relief in emergency department patients
New AEM study finds low-dose ketamine an effective adjunct to morphine for managing acute pain
